Published in Br J Surg on December 09, 2013
Early or Delayed Intervention for Bile Duct Injuries following Laparoscopic Cholecystectomy? A Dilemma Looking for an Answer. Gastroenterol Res Pract (2015) 0.78
Bile Duct Injury after Cholecystectomy: Surgical Therapy. Visc Med (2017) 0.75
Laparoscopic Repair of Post-cholecystectomy Bile Duct Injury: an Advance in Surgical Management. J Gastrointest Surg (2017) 0.75
Pushing the boundaries in liver graft utilisation in transplantation: Case report of a donor with previous bile duct injury repair. Int J Surg Case Rep (2017) 0.75
Liver transplantation in the treatment of severe iatrogenic liver injuries. World J Hepatol (2017) 0.75
An analysis of the problem of biliary injury during laparoscopic cholecystectomy. J Am Coll Surg (1995) 9.03
Complications of laparoscopic cholecystectomy: a national survey of 4,292 hospitals and an analysis of 77,604 cases. Am J Surg (1993) 7.74
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Incidence and nature of bile duct injuries following laparoscopic cholecystectomy: an audit of 5913 cases. West of Scotland Laparoscopic Cholecystectomy Audit Group. Br J Surg (1996) 4.61
Retracted Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy. Br J Surg (2005) 3.06
Laparoscopic cholecystectomy-related bile duct injuries: a health and financial disaster. Ann Surg (1997) 2.41
Advantages of multidisciplinary management of bile duct injuries occurring during cholecystectomy. Am J Surg (2008) 2.11
Open cholecystectomy. A contemporary analysis of 42,474 patients. Ann Surg (1993) 1.95
Liver transplantation: the last measure in the treatment of bile duct injuries. World J Surg (2008) 1.84
Liver resection and transplantation in the management of iatrogenic biliary injury. World J Surg (2007) 1.83
Management and outcome of patients with combined bile duct and hepatic arterial injuries after laparoscopic cholecystectomy. Surgery (2004) 1.82
Malpractice litigation involving laparoscopic cholecystectomy. Cost, cause, and consequences. Arch Surg (1997) 1.82
Non-biliary complication of laparoscopic cholecystectomy. Lancet (1994) 1.64
Incidence and consequence of an hepatic artery injury in patients with postcholecystectomy bile duct strictures. Ann Surg (2003) 1.54
Devastating and fatal complications associated with combined vascular and bile duct injuries during cholecystectomy. Arch Surg (2002) 1.54
Long-term detrimental effect of bile duct injury on health-related quality of life. Arch Surg (2004) 1.49
The dramatic reality of biliary tract injury during laparoscopic cholecystectomy. An anonymous multicenter Belgian survey of 65 patients. Surg Endosc (1997) 1.35
Failed primary management of iatrogenic biliary injury: incidence and significance of concomitant hepatic arterial disruption. Surgery (2001) 1.26
Survival in bile duct injury patients after laparoscopic cholecystectomy: a multidisciplinary approach of gastroenterologists, radiologists, and surgeons. Surgery (2007) 1.25
Major bile duct injuries after laparoscopic cholecystectomy: a tertiary center experience. J Gastrointest Surg (2004) 1.21
Laparoscopic cholecystectomy injury: an unusual indication for liver transplantation. Transpl Int (1998) 1.00
Management and outcome of major bile duct injuries after laparoscopic cholecystectomy: from therapeutic endoscopy to liver transplantation. Liver Transpl (2002) 0.97
Liver transplantation for iatrogenic porta hepatis transection. Am Surg (2009) 0.91
Liver transplantation as an ultimate step in the management of iatrogenic bile duct injury complicated by secondary biliary cirrhosis. Ann Transplant (2012) 0.85
Factors predicting advanced hepatic fibrosis in patients with postcholecystectomy bile duct strictures. Arch Surg (2004) 0.84
Experience using liver transplantation for the treatment of severe bile duct injuries over 20 years in Argentina: results from a National Survey. HPB (Oxford) (2011) 0.83
Liver transplantation as a treatment for complicated bile duct injury. Hepatogastroenterology (2011) 0.81
Bile duct injury during cholecystectomy requiring delayed liver transplantation: a case report and literature review. Tohoku J Exp Med (2006) 0.80
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med (1998) 6.17
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood (1996) 3.39
Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood (1997) 2.12
Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. Br J Haematol (2001) 1.99
Laparoscopic cholecystectomy vs open cholecystectomy in the treatment of acute cholecystitis: a prospective study. Arch Surg (1998) 1.98
Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol (2001) 1.81
Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat Genet (1999) 1.64
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation (2002) 1.64
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study. Aliment Pharmacol Ther (2011) 1.63
Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Subst Use Misuse (2003) 1.55
HIV infection, risk behaviors, and depressive symptoms among Puerto Rican sex workers. Am J Public Health (1994) 1.52
Fulminant hepatic failure after Lepiota mushroom poisoning. J Hepatol (1993) 1.51
[Internal jugular vein catheterization performed by resident and staff physicians]. Rev Esp Anestesiol Reanim (1994) 1.50
Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion (1998) 1.49
Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood (1998) 1.48
Erythropoietin treatment decreases cardiovascular morbidity and mortality in CAPD patients. Perit Dial Int (1997) 1.39
[Acute renal failure caused by cholesterol embolism in kidney transplantation from cadaver donor. Is the prognosis more favorable than in native kidneys?]. Nefrologia (2002) 1.39
Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem (2001) 1.39
Anti-tobacco education in Spanish schools. Allergol Immunopathol (Madr) (1999) 1.39
Two classes of MHC class II interactions with the TCR. Immunol Today (1998) 1.38
Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood (2001) 1.37
Risk factors of acute renal failure after liver transplantation. Kidney Int (2006) 1.36
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood (2001) 1.26
Drug use among public and private secondary school students in Puerto Rico. Int J Addict (1979) 1.23
Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999. J Acquir Immune Defic Syndr (2001) 1.21
A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol Cell Biol (1993) 1.20
Subtotal colectomy vs. intraoperative colonic irrigation in the management of obstructed left colon carcinoma. Dis Colon Rectum (1998) 1.19
Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit. Infect Control Hosp Epidemiol (2008) 1.11
Long-term results of choledochoduodenostomy in the treatment of choledocholithiasis: assessment of 225 cases. Br J Surg (1991) 1.09
Help seeking for mental health care among poor Puerto Ricans: problem recognition, service use, and type of provider. Med Care (1998) 1.08
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant (2002) 1.07
Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens (1997) 1.06
Is DDT use a public health problem in Mexico? Environ Health Perspect (1996) 1.02
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. Am J Transplant (2011) 1.02
In vitro study of magnetic resonance imaging artefacts of six supraglottic airway devices. Anaesthesia (2010) 1.00
Gallamine (Flaxedil) and synaptic transmission in the spinal cord. Science (1968) 1.00
Antibacterial and free-radical scavenging activities of Sonoran propolis. J Appl Microbiol (2007) 1.00
Sublingual administration of tacrolimus in a renal transplant patient. J Clin Pharm Ther (2008) 1.00
Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch Biochem Biophys (2001) 1.00
Growth of hydatid cysts evaluated by CT scanning after presumed cerebral hydatid embolism. Case report. J Neurosurg (1982) 0.98
Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression. Hepatology (2001) 0.98
Analysis of the complications of the piggy-back technique in 1,112 liver transplants. Transplantation (1999) 0.97
Laparoscopic cholecystectomy in the treatment of acute cholecystitis. J Am Coll Surg (1995) 0.97
A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation. Neurochem Int (2004) 0.96
Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders. Adv Perit Dial (2000) 0.95
Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores. Cerebrovasc Dis (2012) 0.95
CRNF, a molluscan neurotrophic factor that interacts with the p75 neurotrophin receptor. Science (1996) 0.95
Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transplant Proc (2003) 0.94
Laparoscopic vs. open cholecystectomy in patients aged 65 and older. Surg Laparosc Endosc (1998) 0.93
Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thromb Haemost (1999) 0.93
Intraperitoneal application of bupivacaine plus morphine for pain relief after laparoscopic cholecystectomy. Eur J Anaesthesiol (2003) 0.93
HIV/AIDS risk factors among adolescent students in Puerto Rico, 1994. Bol Asoc Med P R (1998) 0.93
Quantification of duodenogastric reflux in Barrett's esophagus. Am J Gastroenterol (1997) 0.93
Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation? Transplant Proc (2003) 0.92
[Visceral leishmaniasis in systemic lupus erythematosus]. Med Clin (Barc) (1987) 0.92
"Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant (2014) 0.92
Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution. Bone Marrow Transplant (2005) 0.91
[Thrombocytosis associated with a neoplasm: pathogenic mechanism and clinical significance]. Med Clin (Barc) (1986) 0.91
Gastrointestinal complications in renal transplant recipients: MITOS study. Transplant Proc (2007) 0.91
Global transient amnesia and subclavian steal syndrome. Lancet (1996) 0.91
Lipid peroxidation and antioxidants in erythrocyte membranes of full-term and preterm newborns. Biofactors (1998) 0.91
Rotavirus and hepatitis A virus in market lettuce (Latuca sativa) in Costa Rica. Int J Food Microbiol (1997) 0.91
Electrodeposition of hydroxyapatite coatings in basic conditions. Biomaterials (2000) 0.90
Primary leptomeningeal lymphoma presenting as cerebellopontine angle lesion. Neuroradiology (1994) 0.89
The occurrence of the human glycoconjugate C(2)-alpha-D-mannosylpyranosyl-L-tryptophan in marine ascidians. Org Lett (2000) 0.89
Patterns of mental health utilization among island Puerto Rican poor. Am J Public Health (1991) 0.89
The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: evidence from a large multicenter study in Spain. J Assist Reprod Genet (1996) 0.88
Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis. Transplant Proc (2005) 0.88
Long-term biliary complications after liver surgery leading to liver transplantation. World J Surg (2001) 0.87
Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts. Int Arch Allergy Immunol (2005) 0.87
Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts. Clin Exp Allergy (2007) 0.87
Pancreatic function after severe acute biliary pancreatitis: the role of necrosectomy. Pancreas (2004) 0.86
Convexity meningioma and glioblastoma in collision. Surg Neurol (1990) 0.86
Hepatic artery complications after liver transplantation. Clin Transplant (1994) 0.86
Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates. Transplant Proc (2005) 0.86
Hepatic artery complications in a series of 300 orthotopic liver transplants. Transplant Proc (2000) 0.86
[Liver resection in the treatment of intrahepatic lithiasis. Immediate and long-term results in a single-center series]. Rev Esp Enferm Dig (2008) 0.85
Analysis of the complications of the piggy-back technique in 1112 liver transplants. Transplant Proc (1999) 0.85
Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology (1997) 0.85
Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution. Clin Microbiol Infect (2002) 0.85
Central actions of lidocaine--synaptic transmission. Anesthesiology (1969) 0.85
What predictive parameters best indicate the need for emergent gastrointestinal endoscopy after foreign body ingestion? J Clin Gastroenterol (2000) 0.85
Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia? Haematologica (2000) 0.85
Perinatal morbidity and mortality in twin pregnancies. Int J Gynaecol Obstet (1991) 0.84
Actions of halothane and nitrous oxide on dorsal horn neurons ("The Spinal Gate"). Anesthesiology (1969) 0.84
Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann Surg (2014) 0.84
Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant Proc (2005) 0.84
Has the incidence of perforated peptic ulcer decreased over the last decade? Dig Surg (2001) 0.84
Effect of inhalation anesthetics on monosynaptic and plysynpatic transmission in the spinal cord. J Pharmacol Exp Ther (1968) 0.84
Risk factors of graft loss in orthotopic liver transplantation. Transplant Proc (1998) 0.84
Differential expression of HLA class I and II antigens in primary and metastatic melanomas. J Immunogenet (1987) 0.84
Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies. Horm Metab Res (2009) 0.84
Liver transplantation and transjugular intrahepatic portosystemic shunt. Transplant Proc (2003) 0.84
Influence of sucrose esters on the in vivo percutaneous penetration of octyl methoxycinnamate formulated in nanocapsules, nanoemulsion, and emulsion. Drug Dev Ind Pharm (2006) 0.83
Functional characterization of hepatocytes for cell transplantation: customized cell preparation for each receptor. Cell Transplant (2010) 0.83
[Orthotopic renal transplant: our experience]. Actas Urol Esp (2008) 0.83
Systemic amyloidosis (type AA) in end-stage renal failure patients due to chronic pyelonephritis. Nephron (1991) 0.83